HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Longhi, M. P. Articles by Gallimore, A. Search for Related Content PubMed PubMed Citation Articles by Longhi, M. P. Articles by Gallimore, A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

Cutting Edge: Murine CD59a Modulates Antiviral CD4⁺ T Cell Activity in a Complement-Independent Manner¹

Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Wales, United Kingdom

CD59 blocks formation of the membrane attack complex of complement by inhibiting binding of C9 to the C5b-8 complex. To investigate a role for CD59 in promoting T cell responses, we compared T cell activation in CD59a-deficient (Cd59a^–/–) and wild-type (WT) mice after in vitro stimulation and after infection with rVV. Virus-specific CD4⁺ T cell responses were significantly enhanced in Cd59a^–/– mice compared with WT mice. Similarly, Cd59a^–/– T cells responded more vigorously to in vitro stimulation with CD3-specific Abs compared with WT mice. This effect of CD59a on T cell proliferation was found to be complement-independent. Collectively, these results demonstrate that CD59a down-modulates CD4⁺ T cell activity in vitro and in vivo, thereby revealing another link between complement regulators and T cell activation.

This article has been cited by other articles:

				N. Koch, M. Jung, R. Sabat, J. Kratzschmar, W.-D. Docke, K. Asadullah, H.-D. Volk, and G. Grutz IL-10 protects monocytes and macrophages from complement-mediated lysis J. Leukoc. Biol., July 1, 2009; 86(1): 155 - 166. [Abstract] [Full Text] [PDF]

				A. Muhammad, H. B. Schiller, F. Forster, P. Eckerstorfer, R. Geyeregger, V. Leksa, G. J. Zlabinger, M. Sibilia, A. Sonnleitner, W. Paster, et al. Sequential Cooperation of CD2 and CD48 in the Buildup of the Early TCR Signalosome J. Immunol., June 15, 2009; 182(12): 7672 - 7680. [Abstract] [Full Text] [PDF]

				B. Sivasankar, M. P. Longhi, K. M. E. Gallagher, G. J. Betts, B. P. Morgan, A. J. Godkin, and A. M. Gallimore CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy? J. Immunol., May 1, 2009; 182(9): 5203 - 5207. [Abstract] [Full Text] [PDF]

				J. C. Varela, M. Imai, C. Atkinson, R. Ohta, M. Rapisardo, and S. Tomlinson Modulation of Protective T Cell Immunity by Complement Inhibitor Expression on Tumor Cells Cancer Res., August 15, 2008; 68(16): 6734 - 6742. [Abstract] [Full Text] [PDF]

				C. Fang, T. Miwa, H. Shen, and W.-C. Song Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice J. Immunol., September 1, 2007; 179(5): 3178 - 3186. [Abstract] [Full Text] [PDF]